Status
Conditions
Treatments
About
The primary purpose of the trial is to determine the preliminary efficacy of therapeutic ultrasound in the treatment of pain and sensory disturbance related to chemotherapy induced peripheral neuropathy.
Full description
Thirty cancer patients with colon or colorectal cancer undergoing chemotherapy treatment including the agent oxaliplatin will take part in the study. Patients will be randomly assigned to either standard care alone (education and therapeutic exercises) or standard care plus 10 treatments of therapeutic ultrasound to the toes and fingers.
Participants in both groups will follow a home exercise program for a 6 week period. Therapeutic ultrasound will be administered daily (e.g., Monday to Friday) over the first two week period of the study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
neuropathy pre-existing the patient's cancer diagnosis;
contraindications to therapeutic ultrasound:
peripheral vascular disease or other serious existing non-malignant disease which may affect their ability to complete testing and treatment sessions.
Primary purpose
Allocation
Interventional model
Masking
31 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal